Levy Oded's Form 4/A amendment
AmendedCardio Diagnostics Holdings, Inc. (CDIO) · filed Oct 4, 2023
- Accession no.
- 0001486189-23-000034
- Filed
- Oct 4, 2023, 11:39 AM ET
- Trade date
- Sep 30, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Oct 3, 2023
This filing lists 1 non-derivative transaction and 1 derivative transaction. It was filed 4 days after the trade.
This amendment replaces 0001486189-23-000031 (filed Oct 3, 2023).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Levy OdedCIK 0001950696 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 30, 2023 | Common Stock | MOption exerciseAcquired | +36,765 | $0.34 | +$12,500.1 | 57,773 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 30, 2023 | Restricted Stock Units | PPurchaseDisposed | – | $0.00F4 | – | – | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents the settlement of restricted stock units (RSUs) that vested on September 30, 2023 through the issuance of shares of Common Stock.
- F2
Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On September 30, 2023, $12,500 in value of RSUs vested and were settled at the price of $0.34, which was the closing price of the Company Common Stock on the vesting date. The settlement shares are reflected in Table I.
- F3
On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs, of which $12,500 in value vested on September 30, 2023. Subject to continued service with the Issuer on the vesting date, the remaining $12,500 in value of RSUs will vest on December 31, 2023, based on the closing price of the Issuers common stock on the vesting date.
- F4
The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.
Referenced by the price of 1 transaction in Table II.